Brief: Orgenesis First Quarter 2020 Revenue Increases 348% To $1.9 Million
11/05/2020 12:41
May 11 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS FIRST QUARTER 2020 REVENUE INCREASES 348% TO
$1.9
MILLION REFLECTING SUCCESS OF CGT BIOTECH PLATFORM
* Q1 EARNINGS PER SHARE $4.23
* ORGENESIS - QTRLY REVENUE INCREASED 348% TO $1.9 MILLION
* ORGENESIS - CASH, CASH EQUIVALENTS WERE $107.1 MILLION AS
OF
MARCH 31, 2020
Source text for Eikon: ID:nGNX1LP37Q
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules